検索ワード: tnf (デンマーク語 - 英語)

tnf-hæmmere.
tnf blockers.

andre tnf-hæmmere.
tnf blockers.

kombination med tnf-antagonister
combination with tnf antagonists

tnf- α og il- 6).
specifically, lenalidomide inhibits proliferation of certain haematopoietic tumour cells (including mm plasma tumour cells and those with deletions of chromosome 5), enhances t cell- and natural killer (nk) cell-mediated immunity and increases the number of nk t cells, inhibits angiogenesis by blocking the migration and adhesion of endothelial cells and the formation of microvessels, augments foetal haemoglobin production by cd34+ haematopoietic stem cells, and inhibits production of pro-inflammatory cytokines (e.g., tnf-α and il-6) by monocytes.

utilstrækkeligt respons på tnf-hæmmer
inadequate response to tnf inhibitor

som er anti-tnf-alfa - behandlingsnaive
who are anti-tnfα naïve

samtidig administration af tnf antagonister og anakinra
concurrent administration of tnf-antagonists and anakinra

tumornekrosefaktor- alfa (tnf- α) hæmmere.
tumor necrosis factor alpha (tnf- α) inhibitors.

samtidig behandling med kineret og tnf-antagonist
concurrent kineret and tnf antagonist treatment

tor patienter, der behandles med tnf- antagonister.
with the current knowledge, a possible risk for the development of lymphomas or other malignancies in patients treated with a tnf-antagonist cannot be excluded.

samtidig indgift af tnf-alfahæ mmer og abatacept
concurrent administration of tnf-alpha inhibitor and abatacept

abatacept bør ikke bruges i kombination med tnf-hæmmere.
abatacept is not recommended for use in combination with tnf-inhibitors.

abatacept bør ikke bruges i kombination med tnf- hæmmende midler.
abatacept is not recommended for use in combination with tnf blocking agents.

forsøg utilstrækkeligt respons på tnf-hæmmer studie iii abatacepta placebo
improvement in physical function in placebo-controlled trials inadequate response to inadequate response methotrexate tnf blocking agent study ii study iii abatacepta abatacepta placebo

begge tnf- receptorer eksisterer naturligt i membranbundne og opløselige former.
both tnfrs exist naturally in membrane-bound and soluble forms.

aktiv ra, tidligere behandlet med en eller flere anti-tnf-midler
active ra, previously treated with one or more anti-tnf agent(s)

tumor nekrose faktor alfa (tnf) frembringer betændelse og modulerer cellulært immunrespons.
tumour necrosis factor alpha (tnf) mediates inflammation and modulates cellular immune responses.

raterne for klinisk remission forblev forholdvis konstante uanset tidligere tnf-antagonist- eksposition.
clinical remission results remained relatively constant irrespective of previous tnf-antagonist exposure.

-det aktive stof er tasonermin (tumornekrosefaktor alfa-1a; tnf-1a) fremstillet ved
-the active substance is tasonermin (tumor necrosis factor alfa-1a; tnf-1a) produced by